Dexcom Inc. Aktie
109,48 €
Deine Einschätzung
Dexcom Inc. Aktie
Was spricht für und gegen Dexcom Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Dexcom Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Dexcom Inc. | -1,72 % | -6,73 % | -7,25 % | -4,37 % | -2,22 % | 44,05 % | 305,48 % |
Dentsply Sirona Inc. | 0,39 % | 1,94 % | -2,38 % | -28,74 % | -19,79 % | -52,13 % | -46,46 % |
Zimmer Holdings | -0,33 % | -1,16 % | -6,56 % | -10,99 % | -3,55 % | -19,59 % | 3,29 % |
Baxter International | 0,40 % | 0,59 % | -8,65 % | -18,58 % | -10,33 % | -52,98 % | -51,91 % |
Kommentare
News
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the William Blair 44th Annual Growth
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily